Literature DB >> 15968733

Relation of CagA seropositivity to cagPAI phenotype and histological grade of gastritis in patients with Helicobacter pylori infection.

Tadashi Shimoyama1, Shinsaku Fukuda, Fumika Nakasato, Tetsuro Yoshimura, Tatsuya Mikami, Akihiro Munakata.   

Abstract

AIM: Infection with Helicobacter pylori (H pylori) possessing the cag pathogenicity island (PAI) has been associated with severe clinical outcome and CagA-antibody has been used to indicate cagPAI-positive infection. The aim of this study was to examine the accuracy of CagA seropositivity to indicate the virulence of the cagPAI in Japan.
METHODS: Sixty isolates of H pylori cultured from gastric biopsies were examined by polymerase chain reaction assays for the presence of cagA, cagE and VirD4. Anti-CagA IgG antibody in matching sera was tested by both ELISA and immunoblot assay. Histological grade of gastritis was graded according to the updated Sydney System.
RESULTS: Amongst 53 patients infected with cagA+/cagE+/VirD4+ strain, 38 were CagA seropositive. There were four patients infected with strains possessing incomplete cagPAI. Two out of three patients with cagA+/cagE-/VirD4- infection were CagA seropositive, while a patient with cagA-/cagE+/VirD4+ infection was CagA seronegative. Accuracy of ELISA to predict bacterial possession of cagA was 61.7% whereas 58.3% for cagE and VirD4. The immunoblot assay showed relatively higher sensitivity and showed better accuracy. The lower grade of gastric mucosal inflammatory infiltration was seen in false CagA-seronegative patients.
CONCLUSION: Some serodiagnosis does not seem to have enough accuracy to indicate virulence of cagPAI, particularly in infection of strains with incomplete cagPAI. The degree of gastric mucosal inflammation may affect the results of CagA serodiagnosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15968733      PMCID: PMC4316029          DOI: 10.3748/wjg.v11.i24.3751

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation.

Authors:  M Stein; R Rappuoli; A Covacci
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

2.  Clinical relevance of CagA-specific antibodies related to CagA status of Helicobacter pylori isolates using immunofluorescence test and PCR.

Authors:  R Krausse; L Garten; T Harder; U Ullmann; T Birkner; M Doniec; H Grimm
Journal:  Infection       Date:  2001 May-Jun       Impact factor: 3.553

3.  Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

4.  Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.

Authors:  S Maeda; H Yoshida; K Ogura; Y Yamaji; T Ikenoue; T Mitsushima; H Tagawa; R Kawaguchi; K Mori; K i Mafune; T Kawabe; Y Shiratori; M Omata
Journal:  Cancer       Date:  2000-04-01       Impact factor: 6.860

5.  Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia.

Authors:  T M Peters; R J Owen; E Slater; R Varea; E L Teare; S Saverymuttu
Journal:  J Clin Pathol       Date:  2001-03       Impact factor: 3.411

6.  Distinct mechanism of Helicobacter pylori-mediated NF-kappa B activation between gastric cancer cells and monocytic cells.

Authors:  S Maeda; M Akanuma; Y Mitsuno; Y Hirata; K Ogura; H Yoshida; Y Shiratori; M Omata
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

7.  Serum antibodies anti-H. pylori and anti-CagA: a comparison between four different assays.

Authors:  D Basso; A Stefani; L Brigato; F Navaglia; E Greco; C F Zambon; M G Piva; A Toma; F Di Mario; M Plebani
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

8.  Serologic detection of Helicobacter pylori infection with cagA-positive strains in duodenal ulcer, gastric cancer, and asymptomatic gastritis.

Authors:  S Miehlke; M F Go; J G Kim; D Y Graham; N Figura
Journal:  J Gastroenterol       Date:  1998       Impact factor: 7.527

9.  CagA seropositivity associated with development of gastric cancer in a Japanese population.

Authors:  T Shimoyama; S Fukuda; M Tanaka; T Mikami; A Munakata; J E Crabtree
Journal:  J Clin Pathol       Date:  1998-03       Impact factor: 3.411

10.  Relationship between nuclear factor-kappaB activation and virulence factors of Helicobacter pylori in Japanese clinical isolates.

Authors:  Shin Maeda; Jazag Amarsanaa; Yuzo Mitsuno; Yoshihiro Hirata; Masao Akanuma; Tsuneo Ikenoue; Keiji Ogura; Haruhiko Yoshida; Yasushi Shiratori; Masao Omata; Jazag Anarsanaa
Journal:  J Gastroenterol Hepatol       Date:  2002-05       Impact factor: 4.029

View more
  2 in total

1.  Evaluation of a commercial immunoblot, Helicoblot 2.1, for diagnosis of Helicobacter pylori infection.

Authors:  Lea Veijola; Aino Oksanen; Pentti Sipponen; Hilpi Rautelin
Journal:  Clin Vaccine Immunol       Date:  2008-09-30

2.  Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.

Authors:  Seiji Shiota; Kazunari Murakami; Tadayoshi Okimoto; Masaaki Kodama; Yoshio Yamaoka
Journal:  J Gastroenterol Hepatol       Date:  2014-01       Impact factor: 4.029

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.